packageDoxercalciferol

doxercalciferol

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Doxercalciferol, an ergocalciferol derivative, is used to treat hyperparathyroidism, including secondary hyperparathyroidism of renal origin. It is an approved medicine, classified as an anti-parathyroid agent affecting calcium homeostasis, and is not authorised in the European Union.

Summary written by glm-5.3-flash from Wikidata Q5303688 and the WHO ATC classification; not checked by a person.

name:doxercalciferol
ATC codes:H05BX03
DrugBank:DB06410
PubChem CID:46705423
ChEBI:4712
Wikidata:Q5303688
formula:C28H44O2
molar mass:412.658 g/mol (PubChem CID 46705423)
logP:6.3 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown